Duarte, CA, United States of America

Kurt Jenkins

USPTO Granted Patents = 3 

Average Co-Inventor Count = 3.3

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2019-2024

Loading Chart...
3 patents (USPTO):

Title: Kurt Jenkins: Innovator in Cancer Treatment

Introduction

Kurt Jenkins is a notable inventor based in Duarte, CA (US). He has made significant contributions to the field of cancer treatment through his innovative work. With a total of 3 patents, Jenkins has focused on developing recombinant proteins that target CTLA-4, a protein involved in tumor growth.

Latest Patents

One of his latest patents is the CTLA4-binding protein peptide-linker masks. This invention provides recombinant CTLA-4 binding proteins that are useful for treating cancer. The proteins are designed to bind to CTLA-4 proteins on tumor cells, enhancing the effectiveness of cancer therapies. Another significant patent is for tumor-selective CTLA-4 antagonists. This invention includes recombinant masking proteins and ligand proteins that can be used to treat cancer, neurodegenerative diseases, and cardiovascular diseases.

Career Highlights

Throughout his career, Kurt Jenkins has worked with esteemed institutions such as City of Hope and Thomas Jefferson University. His work has been pivotal in advancing the understanding and treatment of various diseases, particularly cancer.

Collaborations

Jenkins has collaborated with notable colleagues, including John C. Williams and Ulrich Rodeck. These partnerships have contributed to the development of innovative solutions in the medical field.

Conclusion

Kurt Jenkins is a prominent inventor whose work in recombinant proteins has the potential to revolutionize cancer treatment. His patents reflect a commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…